Galectin Therapeutics Inc (GALT)
3.37
-0.13
(-3.71%)
USD |
NASDAQ |
May 02, 16:00
3.37
0.00 (0.00%)
After-Hours: 18:49
Galectin Therapeutics Total Assets (Quarterly): 28.20M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 28.20M |
September 30, 2023 | 22.16M |
June 30, 2023 | 20.08M |
March 31, 2023 | 20.22M |
December 31, 2022 | 21.28M |
September 30, 2022 | 17.91M |
June 30, 2022 | 25.89M |
March 31, 2022 | 33.62M |
December 31, 2021 | 41.83M |
September 30, 2021 | 38.04M |
June 30, 2021 | 33.40M |
March 31, 2021 | 22.90M |
December 31, 2020 | 29.60M |
September 30, 2020 | 34.05M |
June 30, 2020 | 41.32M |
March 31, 2020 | 44.11M |
December 31, 2019 | 48.47M |
September 30, 2019 | 50.76M |
June 30, 2019 | 53.01M |
March 31, 2019 | 7.83M |
December 31, 2018 | 9.006M |
September 30, 2018 | 10.62M |
June 30, 2018 | 11.21M |
March 31, 2018 | 4.931M |
December 31, 2017 | 4.161M |
Date | Value |
---|---|
September 30, 2017 | 7.011M |
June 30, 2017 | 9.329M |
March 31, 2017 | 14.00M |
December 31, 2016 | 15.80M |
September 30, 2016 | 16.12M |
June 30, 2016 | 18.25M |
March 31, 2016 | 22.79M |
December 31, 2015 | 26.41M |
September 30, 2015 | 21.51M |
June 30, 2015 | 26.68M |
March 31, 2015 | 29.97M |
December 31, 2014 | 29.68M |
September 30, 2014 | 31.32M |
June 30, 2014 | 34.59M |
March 31, 2014 | 36.90M |
December 31, 2013 | 10.71M |
September 30, 2013 | 9.777M |
June 30, 2013 | 5.225M |
March 31, 2013 | 7.196M |
December 31, 2012 | 9.561M |
September 30, 2012 | 11.19M |
June 30, 2012 | 13.32M |
March 31, 2012 | 15.54M |
December 31, 2011 | 6.612M |
September 30, 2011 | 8.103M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
17.91M
Minimum
Sep 2022
53.01M
Maximum
Jun 2019
32.99M
Average
33.40M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 640.55M |
Viking Therapeutics Inc | 967.52M |
89bio Inc | 596.27M |
Terns Pharmaceuticals Inc | 268.52M |
Enanta Pharmaceuticals Inc | 428.50M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 88.44M |
Shareholders Equity (Quarterly) | -60.24M |